Deals
Pfizer to Terminate $160 Billion Merger With Allergan
Pfizer Said to Scrap $160B Allergan Deal
This article is for subscribers only.
Pfizer Inc. decided to terminate its $160 billion merger with Allergan Plc, a person familiar with the matter said, marking an end to the largest-ever health-care acquisition as officials in Washington crack down on corporate inversions.